Month: February 2023

Case Report

Ultrafast regimen for Pru p3 sublingual immunotherapy (SLIT-Peach) in patients with anaphylactic LTP-Syndrome

/ by almaware | Leave a Comment

Sublingual immunotherapy with Pru p3 extract (SLIT-peach®) is used in allergy patients to multiple plant foods to induce tolerance to nonspecific lipid transfer proteins (nsLTP). The aim of this paper is to communicate the efficacy of a new ultrafast regimen. Until now on the initiation regimen lasts four days. We present a number of 22 […]

Read more »

Original Article

Immunological and molecular study in children with combined immunodeficiency

/ by almaware | Leave a Comment

Background. Severe combined immunodeficiency (SCID) is a form of immunodeficiencies (PID), caused by molecular defects. These defects can restrict the development and function of lymphocytes. Early diagnosis and treatment of SCID can lead to disease-free survival. This study aims to inves­tigate some of the possible underlying genetic defects in a group of Egyptian infants and […]

Read more »

Letter to the Editor

Clinical characterization of peach allergic patients and respective molecular sensitization profile with ALEX®2 macroarray

/ by almaware | Leave a Comment

Read more »

Letter to the Editor

Atopic status and thyroid autoimmunity do not predict omalizumab response in severe chronic spontaneous urticaria patients

/ by almaware | Leave a Comment

Read more »

To top